Loading…
Bionano Genomics, Inc. is projected to decline to $1.06 by 2027, a -5% move from its current price of $1.12. BNGO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.09 | $1.12 | $1.14 | +0.02% |
| Aug 6 | $1.08 | $1.12 | $1.15 | +0.03% |
| Aug 7 | $1.08 | $1.12 | $1.16 | +0.05% |
| Aug 8 | $1.07 | $1.12 | $1.16 | +0.07% |
| Aug 9 | $1.06 | $1.12 | $1.17 | +0.09% |
| Aug 10 | $1.06 | $1.12 | $1.18 | +0.10% |
| Aug 11 | $1.06 | $1.12 | $1.18 | +0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.06 | $1.12 | $1.18 | +0.12% |
| Week 2 | $1.03 | $1.12 | $1.21 | +0.24% |
| Week 3 | $1.02 | $1.12 | $1.23 | +0.37% |
| Week 4 | $1.00 | $1.12 | $1.25 | +0.49% |
| Week 5 | $0.989 | $1.12 | $1.27 | +0.61% |
| Week 6 | $0.9784 | $1.12 | $1.29 | +0.73% |
| Week 7 | $0.9688 | $1.12 | $1.31 | +0.85% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bionano Genomics, Inc. is a Healthcare company that provides genome analysis solutions across the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr and Stratys instruments, which are single-molecule imagers; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA; and Ionic purification system, which isolates and purifies nucleic acid molecules. In addition, the company offers Saphyr, Stratys, and Bionano compute servers; and VIA software, which offers one solution for cytogenetics and molecular genetics. Further, it provides testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing.
Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
BNGO is a healthcare company focused on genome analysis solutions, including software and systems for analyzing genetic data and identifying structural variation. The stock is currently priced at $1.06 with a market capitalization of $12.16M and it is ranked 4753 by market cap. The share price and market position reflect a small-cap biotechnology exposure with a defined suite of tools and services for genetic analysis.
The forecast suggests a path from neutral to bullish over the coming years, with average prices rising from $1.06 in 2026 to higher levels by 2031 and beyond, including a 2050 average of $3.02 and a 2050 max of $5.12, yielding a long-run upside in the range indicated by the model’s numbers.
A major floor 13.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.9% below — buyers have tended to step in here.
The nearest ceiling, 7.6% above — a clean break opens room to run.
A major ceiling 19.3% above — clearing it would confirm fresh momentum.
Key BNGO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BNGO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.08 | Buy | $1.08 | Buy |
| MA 10 | $1.10 | Buy | $1.10 | Buy |
| MA 20 | $1.13 | Sell | $1.12 | Sell |
| MA 50 | $1.16 | Sell | $1.15 | Sell |
| MA 100 | $1.18 | Sell | $1.24 | Sell |
| MA 200 | $1.35 | Sell | $2.55 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.31 | Neutral |
| Stoch RSI (14) | 13.96 | Buy |
| CCI (20) | -126.47 | Sell |
| Williams %R (14) | -92.31 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -10.08 | Sell |
| Bollinger %B (20,2) | 0.11 | Neutral |
| Stochastic %K (14) | 7.69 | Buy |
| TRIX (15) | -0.22 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 26.58 | Buy |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 1.06 | Buy |
| ADX (14) | 15.47 | Neutral |
| ATR (14) | 0.02 | Info |
Technically, the near term shows bearish momentum with RSI(14) at 30. The stock trades with SMA50 at $1.17 and SMA200 at $1.36, placing the current price below the short- and longer-term moving averages. The stock sits at a support level of $1.06 with resistance at $1.20, and the 30-day price range spans from $0.9212 to $1.22.
These factors together create a cautious near-term outlook, with downside pressure and a potential for limited upside within the current trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.06 | $1.12 | $1.43 | 0% | Neutral | |
| $0.8595 | $1.06 | $1.36 | -5% | Neutral | |
| $0.8834 | $1.11 | $1.47 | 0% | Neutral | |
| $0.8619 | $1.10 | $1.50 | -1% | Neutral | |
| $0.8519 | $1.11 | $1.53 | -1% | Neutral | |
| $0.9776 | $1.29 | $1.82 | +15% | Neutral | |
| $1.02 | $1.36 | $1.95 | +22% | Bullish | |
| $1.04 | $1.40 | $2.04 | +25% | Bullish | |
| $1.04 | $1.42 | $2.09 | +27% | Bullish | |
| $0.9809 | $1.35 | $2.02 | +21% | Bullish | |
| $1.30 | $1.88 | $2.96 | +69% | Bullish | |
| $1.87 | $2.95 | $5.00 | +164% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.06 | $1.12 | $1.36 | +0.00% |
| September 2026 | $0.9675 | $1.14 | $1.37 | +1.95% |
| October 2026 | $0.959 | $1.13 | $1.37 | -0.35% |
| November 2026 | $0.9773 | $1.16 | $1.42 | +2.35% |
| December 2026 | $0.9745 | $1.16 | $1.43 | +0.11% |
Click any year to see its month-by-month BNGO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BNGO is projected to trade between $1.06 and $1.43, averaging $1.12 — a potential gain of 0% from today's $1.12. A consolidation phase looks the most probable path here.
Bionano Genomics, Inc.'s 2027 outlook centres on $1.06, within a $0.8595 to $1.36 range. That is -5% versus the projected 2026 average. That marks a -5% change versus current levels. Price action looks broadly range-bound.
By 2028, BNGO could reach as high as $1.47, with a base case around $1.11 and support toward $0.8834 — roughly 0% from $1.12. A consolidation phase looks the most probable path here.
Expect BNGO to range from $0.8619 to $1.50 through 2029. The $1.10 average target implies a -1% move from current prices. That is -1% versus the projected 2028 average. Price action looks broadly range-bound.
The BNGO price prediction for 2030 points to an average of $1.11 (low $0.8519, high $1.53) — a potential decline of -1% on today's $1.12. A consolidation phase looks the most probable path here.
In 2031, BNGO is projected to trade between $0.9776 and $1.82, averaging $1.29 — a potential gain of +15% from today's $1.12. That is up +16% on the projected 2030 average. Price action looks broadly range-bound.
Bionano Genomics, Inc.'s 2032 outlook centres on $1.36, within a $1.02 to $1.95 range. That is up +5% on the projected 2031 average. That marks a +22% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, BNGO could reach as high as $2.04, with a base case around $1.40 and support toward $1.04 — roughly +25% from $1.12. Momentum favours further upside here.
Expect BNGO to range from $1.04 to $2.09 through 2034. The $1.42 average target implies a +27% move from current prices. That is up +1% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The BNGO price prediction for 2035 points to an average of $1.35 (low $0.9809, high $2.02) — a potential gain of +21% on today's $1.12. Momentum favours further upside here.
In 2040, BNGO is projected to trade between $1.30 and $2.96, averaging $1.88 — a potential gain of +69% from today's $1.12. That is up +39% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Bionano Genomics, Inc.'s 2050 outlook centres on $2.95, within a $1.87 to $5.00 range. That is up +57% on the projected 2040 average. That marks a +164% change versus current levels. Momentum favours further upside here.
Investing $1,000 in BNGO today (≈ 896.860987 BNGO) could be worth
$2,644.55
+$1,644.55 (+164%) by 2050 · US Dollar
Based on the average projected BNGO price of $2.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BNGOwould be worth at today's price.
$1,000 invested in BNGO on Jul 31, 2025 (≈ 332.225915 BNGO) would be worth
$370.43
-$629.57 (-63.0%) today · 0.37× · US Dollar
Based on a BNGO entry price of $3.01 vs. today's $1.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.11 | $1,004.5 | +0.5% |
| 1 month ago | $1.17 | $952.99 | -4.7% |
| 3 months ago | $1.18 | $944.92 | -5.5% |
| 6 months ago | $1.27 | $877.95 | -12.2% |
| 1 year ago | $3.01 | $370.43 | -63.0% |
| All time (5.0y) ago | $3,744 | $0.3 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BNGO forecast.
Our base-case forecast reaches $2.20 around 2050.
Implied market cap at $2.20: $25.25M
Over the multi-year horizon, the forecast shows the price moving from neutral in 2026 to bullish in the years that follow. The 2026 forecast has an avg of $1.06 with ROI of 0 and a neutral sentiment. By 2030 the avg is $1.09 with ROI 3.3 and neutral sentiment.
In 2031 the avg rises to $1.29 with ROI 21.6 and a bullish sentiment, followed by 2032 avg $1.35 with ROI 26.9, 2033 avg $1.39 with ROI 30.8, and 2034 avg $1.41 with ROI 33.3, all with bullish or neutral dispositions. By 2040 the avg reaches $1.91 with ROI 80.1 and bullish sentiment, and by 2050 the avg is $3.02 with ROI 184.6 and bullish sentiment, with a max price in 2050 of $5.12. This implies meaningful upside potential over the long run, punctuated by higher highs and expanding sentiment toward bullishness after 2031.
These are estimates and not guarantees; they reflect modeled projections and are subject to market conditions and other risks.
Tap a question to reveal the answer.
Avg $1.09, min $0.8433, max $1.52, ROI 3.3, sentiment NEUTRAL.
The forecast shows increasing averages starting 2031 (avg $1.29, ROI 21.6, sentiment BULLISH) and continuing to 2040 (avg $1.91, ROI 80.1) and 2050 (avg $3.02, ROI 184.6). These are estimates and not guarantees.
Yes, the forecast max price by 2050 is $5.12 with ROI 184.6 and bullish sentiment.
Current price is $1.06 and market cap is $12.16M.
The 30-day range is from $0.9212 to $1.22.
Bionano Genomics, Inc. Community Discussion
0Share your Bionano Genomics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.